General Information of Drug (ID: DMEPWYA)

Drug Name
THIOCOLCHICOSIDE Drug Info
Synonyms
Thiocolchicoside; 602-41-5; Coltramyl; UNII-T1X8S697GT; Thiocolchicine 2-glucoside analog; NSC 147755; Musco-ril; T1X8S697GT; 10-Thiocolchicoside; Tiocolchicoside [DCIT]; Colchicoside, 10-thio-; Thiocolchicoside [INN:DCF]; Q-201823; Thiocolchicosidum [INN-Latin]; Tiocolchicosido [INN-Spanish]; C27H33NO10S; Tiocolchicosido; Tiocolchicoside; Muscoril; Thiocolchicosidum; EINECS 210-017-7; BRN 0072205; R. 271; 2-10-Di(demethoxy)-2-glucosyloxy-10-methylthiocolchicine; Miotens; Coltrax; NSC147755; Coltramyl (TN); NCGC00016519-01
Indication
Disease Entry ICD 11 Status REF
Muscle spasm MB47.3 Approved [1]
Cross-matching ID
PubChem CID
9915886
ChEBI ID
CHEBI:94557
CAS Number
CAS 602-41-5
TTD Drug ID
DMEPWYA

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Discontinued Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Allopregnanolone DMNLHAC Depression 6A70-6A7Z approved [3]
ZK-93423 DMFWMKZ Epileptic seizures 8A61-8A6Z Phase 3 [4]
GSK683699 DMTW79H Inflammatory bowel disease DD72 Phase 2 [2]
ELTANOLONE DM38CIV Premenstrual syndrome GA34.40 Discontinued in Phase 3 [3]
U-78875 DM2WOPX Anxiety disorder 6B00-6B0Z Discontinued in Phase 1 [5]
CGS-9896 DM39PQI N. A. N. A. Terminated [6]
CGS-17867A DMMZJY3 Alcohol dependence 6C40.2 Terminated [7]
TBPS DMFC3XP Discovery agent N.A. Investigative [8]
AMENTOFLAVONE DMLRNV2 Discovery agent N.A. Investigative [9]
Ro-15-3505 DM4NW3U Discovery agent N.A. Investigative [10]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
D-Serine DM3YH4I N. A. N. A. Phase 4 [11]
GINKOLIDE B DMLIM7B Sepsis 1G40-1G41 Terminated [12]
3-demethoxy-3-D-lyxopyranosylaminothiocolchicine DME8VPC Discovery agent N.A. Investigative [2]
3-demethoxy-3-D-xylopyranosylaminothiocolchicine DMXFVD1 Discovery agent N.A. Investigative [2]
3-demethoxy-3-L-fucopyranosylaminothiocolchicine DM4ERYF Discovery agent N.A. Investigative [2]
3-demethoxy-3D-glucopyranosylaminothiocolchicine DMID7TC Discovery agent N.A. Investigative [2]
3-demethoxy-3-D-mannopyranosylaminothiocolchicine DMALMGH Discovery agent N.A. Investigative [2]
GINKGOLIDE A DMKZJ7T Discovery agent N.A. Investigative [12]
Ginkgolide J DMUOMP1 Discovery agent N.A. Investigative [12]
Ginkgolide C DMVN374 Discovery agent N.A. Investigative [12]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ethanol DMDRQZU Chronic pain MG30 Approved [13]
Zolpidem DMWOSKJ Insomnia 7A00-7A0Z Approved [14]
Methoxyflurane DML0RAE Anaesthesia 9A78.6 Approved [13]
Nitrazepam DMEGIQ6 Epilepsy 8A60-8A68 Approved [13]
Allopregnanolone DMNLHAC Depression 6A70-6A7Z approved [3]
Clobazam - Lundbeck DMW1OQ0 Anxiety disorder 6B00-6B0Z Approved [13]
Hexobarbital DMQ314B Anaesthesia 9A78.6 Approved [13]
Meprobamate DMHM93Y Anxiety Approved [13]
Zaleplon DMGFWSM Insomnia 7A00-7A0Z Approved [15]
Ethchlorvynol DM53IP1 Insomnia 7A00-7A0Z Approved [13]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Targeting Glycine receptor (GlyR)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ZD-9379 DM3KYO4 Cerebrovascular ischaemia 8B1Z Phase 1 [16]
UK-240455 DMSCXB7 Nerve injury ND56.4 Phase 1 [17]
MDL-27531 DMC60S8 Epilepsy 8A60-8A68 Phase 1 [18]
Gavestinel DM8IL1U Nerve injury ND56.4 Discontinued in Phase 2 [19]
GV-196771 DMFN21T Migraine 8A80 Discontinued in Phase 2 [20]
GW 468816 DMQ92WF Tobacco dependence 6C4A.2 Discontinued in Phase 2 [21]
M-241247 DMIY51U Cerebrovascular ischaemia 8B1Z Terminated [22]
GINKOLIDE B DMLIM7B Sepsis 1G40-1G41 Terminated [12]
3-demethoxy-3-D-lyxopyranosylaminothiocolchicine DME8VPC Discovery agent N.A. Investigative [2]
3-demethoxy-3-D-xylopyranosylaminothiocolchicine DMXFVD1 Discovery agent N.A. Investigative [2]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [13]
Allopregnanolone DMNLHAC Depression 6A70-6A7Z approved [23]
Clonazepam DMTO13J Absence epilepsy Approved [24]
Piperazine DMTY9LU Ascariasis 1F62 Approved [25]
Alpidem DMN7Y9K Anxiety disorder 6B00-6B0Z Approved [26]
Moxidectin DMYGHX5 Onchocerciasis 1F6A Approved [27]
DP-VPA DMGOXPQ Bipolar disorder 6A60 Approved [28]
ANDROSTERONE DMITJAK N. A. N. A. Phase 3 [23]
ZK-93423 DMFWMKZ Epileptic seizures 8A61-8A6Z Phase 3 [4]
GSK683699 DMTW79H Inflammatory bowel disease DD72 Phase 2 [2]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Allopregnanolone DMNLHAC Depression 6A70-6A7Z approved [3]
Ethchlorvynol DM53IP1 Insomnia 7A00-7A0Z Approved [13]
ZK-93423 DMFWMKZ Epileptic seizures 8A61-8A6Z Phase 3 [4]
GSK683699 DMTW79H Inflammatory bowel disease DD72 Phase 2 [2]
ELTANOLONE DM38CIV Premenstrual syndrome GA34.40 Discontinued in Phase 3 [3]
U-78875 DM2WOPX Anxiety disorder 6B00-6B0Z Discontinued in Phase 1 [29]
CGS-9896 DM39PQI N. A. N. A. Terminated [6]
TBPS DMFC3XP Discovery agent N.A. Investigative [30]
AMENTOFLAVONE DMLRNV2 Discovery agent N.A. Investigative [9]
Ro-15-3505 DM4NW3U Discovery agent N.A. Investigative [10]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
GABA(A) receptor alpha-1 (GABRA1) TT1MPAY GBRA1_HUMAN Inhibitor [2]
GABA(A) receptor beta-2 (GABRB2) TTZA1NY GBRB2_HUMAN Inhibitor [2]
GABA(A) receptor gamma-2 (GABRG2) TT06RH5 GBRG2_HUMAN Inhibitor [2]
Gamma-aminobutyric acid receptor (GAR) TTNJYV2 NOUNIPROTAC Inhibitor [2]
Glycine receptor (GlyR) TTZ8EM9 GLRA1_HUMAN; GLRA2_HUMAN; GLRA3_HUMAN; GLRA4_HUMAN; GLRB_HUMAN Inhibitor [2]
Strychnine-binding glycine receptor (GLRA1) TTF45NW GLRA1_HUMAN Inhibitor [2]

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 3-demethoxy-3-glycosylaminothiocolchicines: Synthesis of a new class of putative muscle relaxant compounds. J Med Chem. 2006 Sep 7;49(18):5571-7.
3 Neurosteroid analogues. 10. The effect of methyl group substitution at the C-6 and C-7 positions on the GABA modulatory and anesthetic actions of (... J Med Chem. 2005 Apr 21;48(8):3051-9.
4 Structural requirements for agonist actions at the benzodiazepine receptor: studies with analogues of 6-(benzyloxy)-4-(methoxymethyl)-beta-carbolin... J Med Chem. 1990 Mar;33(3):1062-9.
5 3-Phenyl-substituted imidazo[1,5-alpha]quinoxalin-4-ones and imidazo[1,5-alpha]quinoxaline ureas that have high affinity at the GABAA/benzodiazepin... J Med Chem. 1996 Sep 13;39(19):3820-36.
6 Synthesis, pharmacology, and structure-activity relationships of novel imidazolones and pyrrolones as modulators of GABAA receptors. J Med Chem. 2006 Mar 23;49(6):1855-66.
7 2,5-Dihydropyrazolo[4,3-c]pyridin-3-ones: functionally selective benzodiazepine binding site ligands on the GABAA receptor. Bioorg Med Chem Lett. 2004 Jul 5;14(13):3441-4.
8 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 414).
9 Semisynthetic preparation of amentoflavone: A negative modulator at GABA(A) receptors. Bioorg Med Chem Lett. 2003 Jul 21;13(14):2281-4.
10 Synthesis and evaluation of imidazo[1,5-a][1,4]benzodiazepine esters with high affinities and selectivities at "diazepam-insensitive" benzodiazepin... J Med Chem. 1993 Apr 16;36(8):1001-6.
11 Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.
12 Probing the pharmacophore of ginkgolides as glycine receptor antagonists. J Med Chem. 2007 Apr 5;50(7):1610-7.
13 DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2008 Jan;36(Database issue):D901-6.
14 Zolpidem, a selective GABA(A) receptor alpha1 subunit agonist, induces comparable Fos expression in oxytocinergic neurons of the hypothalamic paraventricular and accessory but not supraoptic nuclei in the rat.Brain Res Bull.2006 Dec 11;71(1-3):200-7.
15 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
16 Neuroprotective potential of ionotropic glutamate receptor antagonists. Neurotox Res. 2002 Mar;4(2):119-26.
17 UK-315716/UK-240455. Pfizer. Curr Opin Investig Drugs. 2001 Dec;2(12):1737-9.
18 MDL 27,531 reduces spontaneous hindlimb contractions in rats with chronic transections of the spinal cord. Neurosci Lett. 1992 Nov 23;147(1):101-5.
19 Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial.GAIN International Investigators.Lancet.2000 Jun 3;355(9219):1949-54.
20 First time in human for GV196771: interspecies scaling applied on dose selection. J Clin Pharmacol. 1999 Jun;39(6):560-6.
21 A double-blind, placebo-controlled trial of the NMDA glycine site antagonist, GW468816, for prevention of relapse to smoking in females.J Clin Psychopharmacol.2011 Oct;31(5):597-602.
22 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003415)
23 Neurosteroid analogues. 11. Alternative ring system scaffolds: gamma-aminobutyric acid receptor modulation and anesthetic actions of benz[f]indenes. J Med Chem. 2006 Jul 27;49(15):4595-605.
24 Glutamate- and GABA-based CNS therapeutics. Curr Opin Pharmacol. 2006 Feb;6(1):7-17.
25 Cyclooctadepsipeptides--an anthelmintically active class of compounds exhibiting a novel mode of action. Int J Antimicrob Agents. 2003 Sep;22(3):318-31.
26 Synthesis and binding affinity of 2-phenylimidazo[1,2-alpha]pyridine derivatives for both central and peripheral benzodiazepine receptors. A new se... J Med Chem. 1997 Sep 12;40(19):3109-18.
27 2018 FDA drug approvals.Nat Rev Drug Discov. 2019 Feb;18(2):85-89.
28 DP-VPA D-Pharm. Curr Opin Investig Drugs. 2002 Jun;3(6):921-3.
29 High-affinity alpha-aminobutyric acid A/benzodiazepine ligands: synthesis and structure-activity relationship studies of a new series of tetracycli... J Med Chem. 1996 Nov 8;39(23):4654-66.
30 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 411).